Concepedia

Paige Baldwin

PB

Statistics

Publications

8

Citations

301

H-Index

8

Active since

1985

Affiliations

Northeastern University(Current)

Harvard University

Michigan State University

Brigham and Women's Hospital

Paige Baldwin is an author at Northeastern University specializing in oncology, medicine, and cancer therapeutics.

ORCID

Top concepts

Publications per year

1985–2019

8

Publications

8

A nano-liposome formulation of the PARP inhibitor Talazoparib enhances treatment efficacy and modulates immune cell populations in mammary tumors of BRCA-deficient mice

Di Zhang, Paige Baldwin, Ana S. Leal et al. · Theranostics · 2019 · 64 citations · Full text

Nanoformulation of Olaparib Amplifies PARP Inhibition and Sensitizes <i>PTEN/TP53-</i> Deficient Prostate Cancer to Radiation

Anne L. van de Ven, Shifalika Tangutoori, Paige Baldwin et al. · Molecular Cancer Therapeutics · 2017 · 52 citations · Full text

Combined modality therapy with radiotherapy, chemotherapy, and immunotherapy in limited small-cell carcinoma of the lung: a Phase III cancer and Leukemia Group B Study.

L. Herbert Maurer, Thomas F. Pajak, Walter L. Eaton et al. · Journal of Clinical Oncology · 1985 · 49 citations

, , +20

A phase I–II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma

CH Weaver, FA Greco, J. D. Hainsworth et al. · Bone Marrow Transplantation · 1997 · 29 citations

, , +8

Sustained Release Talazoparib Implants for Localized Treatment of <i>BRCA1</i>-deficient Breast Cancer

Jodi Belz, Rajiv Kumar, Paige Baldwin et al. · Theranostics · 2017 · 29 citations · Full text

Rows per page

1–5 of 8